» Articles » PMID: 25859280

IRS-1 Gene Polymorphism and DNA Damage in Pregnant Women with Diabetes or Mild Gestational Hyperglycemia

Overview
Publisher Biomed Central
Specialty Endocrinology
Date 2015 Apr 11
PMID 25859280
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pregnant women with mild gestational hyperglycemia present a high risk for hypertension and obesity, and appear to reproduce the model of metabolic syndrome in pregnancy, including hyperinsulinemia and insulin resistance. Diabetic patients have a higher frequency of the IRS-1 Gly972Arg variant and this polymorphism is directly related to insulin resistance and subsequent hyperglycemia. In diabetes, hyperglycemia and other associated factors generate reactive oxygen species that increase DNA damage. The aims of this study were to evaluate the presence of the IRS-1 Arg972 polymorphism in pregnant women with diabetes or mild gestational hyperglycemia, and in their newborns. Additionally, we evaluated the level of primary DNA damage in lymphocytes of Brazilian pregnant women and the relationship between the amount of genetic damage and presence of the polymorphism.

Methods: A based on the oral glucose tolerance test (OGTT) results and on glycemic profiles (GP), as follows: non-diabetic group, mild gestational hyperglycemia (MGH) and diabetic group. Eighty-five newborns were included in the study. Maternal peripheral blood samples and umbilical cord blood samples (5-10 mL) were collected for genotyping by PCR-RFLP and for comet assays.

Results: The prevalence of genotype Gly/Arg in pregnant women groups was not statistically significant. In newborns, the frequency of Gly/Arg was significantly higher in the MGH and diabetic groups than in the non-diabetic group. Taken together, groups IIA and IIB (IIA + IIB; diabetes) presented lower amounts of DNA damage than the non-diabetic group (p = 0.064). No significant association was detected between genetic damage and the presence of the Arg972 genotype in pregnant women.

Conclusion: The polymorphism was more prevalent in newborns of diabetic and MGH women. We believe that it is necessary to increase the number of subjects to be examined in order to better determine the biological role of the Arg972 polymorphism in these patients. Despite being classified as low-risk, pregnant women with mild gestational hyperglycemia characterize a population of maternal and perinatal adverse outcomes, and that, together with their newborns, require better monitoring by professionals and health services.

Citing Articles

Diabetes, Oxidative Stress, and DNA Damage Modulate Cranial Neural Crest Cell Development and the Phenotype Variability of Craniofacial Disorders.

Fitriasari S, Trainor P Front Cell Dev Biol. 2021; 9:644410.

PMID: 34095113 PMC: 8174788. DOI: 10.3389/fcell.2021.644410.


Association of IRS1 Gly972Arg and IRS2 Gly1057Asp polymorphisms with gastric cancer in Turkish subjects.

Gorgisen G, Karatas U, Ates C, Oksuz M, Gulacar I Oncol Lett. 2020; 20(2):2016-2020.

PMID: 32724448 PMC: 7377191. DOI: 10.3892/ol.2020.11717.


An integrative review of associations between polymorphic variants and the metabolic syndrome.

Oliveira J, Silva de Oliveira Boery R J Vasc Bras. 2018; 17(2):141-147.

PMID: 30377424 PMC: 6205710. DOI: 10.1590/1677-5449.007917.


From Sea to Shining Sea and the Great Plains to Patagonia: A Review on Current Knowledge of Diabetes Mellitus in Hispanics/Latinos in the US and Latin America.

Aviles-Santa M, Colon-Ramos U, Lindberg N, Mattei J, Pasquel F, Perez C Front Endocrinol (Lausanne). 2017; 8:298.

PMID: 29176960 PMC: 5687125. DOI: 10.3389/fendo.2017.00298.


Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy.

Lindblom R, Higgins G, Coughlan M, de Haan J Rev Diabet Stud. 2015; 12(1-2):134-56.

PMID: 26676666 PMC: 5397988. DOI: 10.1900/RDS.2015.12.134.

References
1.
Porzio O, Federici M, Hribal M, Lauro D, Accili D, Lauro R . The Gly972-->Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells. J Clin Invest. 1999; 104(3):357-64. PMC: 408413. DOI: 10.1172/JCI5870. View

2.
Imai Y, Fusco A, Suzuki Y, Lesniak M, DAlfonso R, Sesti G . Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1994; 79(6):1655-8. DOI: 10.1210/jcem.79.6.7989470. View

3.
Negrato C, Jovanovic L, Tambascia M, Calderon I, Geloneze B, Dias A . Mild gestational hyperglycaemia as a risk factor for metabolic syndrome in pregnancy and adverse perinatal outcomes. Diabetes Metab Res Rev. 2008; 24(4):324-30. DOI: 10.1002/dmrr.815. View

4.
Jellema A, Mensink R, Kromhout D, Saris W, Feskens E . Metabolic risk markers in an overweight and normal weight population with oversampling of carriers of the IRS-1 972Arg-variant. Atherosclerosis. 2003; 171(1):75-81. DOI: 10.1016/j.atherosclerosis.2003.08.002. View

5.
Siu P, Pei X, Teng B, Benzie I, Ying M, Wong S . Habitual exercise increases resistance of lymphocytes to oxidant-induced DNA damage by upregulating expression of antioxidant and DNA repairing enzymes. Exp Physiol. 2011; 96(9):889-906. DOI: 10.1113/expphysiol.2011.058396. View